INSIGHTFUL-FFR Clinical Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2500 participants.

Also called NCT05437900

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,500 participants (planned count) (from the registry)
Sponsor
CoreAalst BV (from the registry)
Registry
  • NCT NCT05437900
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, China, France, Germany, Italy, Netherlands, Poland, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05437900. Randomized; no masking; primary purpose treatment. Start 2022-09-22 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
INSIGHTFUL-FFR Clinical Trial
Condition
Acute Coronary Syndrome
Intervention (Procedure)
Pressure Microcatheter guided strategy - PIOS MC
Intervention (Procedure)
Pressure Wire guided strategy - PIOS - PW
Intervention (Procedure)
Pressure Microcatheter guided strategy - Standard of care
Intervention (Procedure)
Pressure Wire guided strategy - Standard of care
Lead sponsor
CoreAalst BV (class: industry)
Collaborator
Insight Lifetech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05437900
Content hash
d24edc306506f5fd8bb0c320562a90994ef7b6ce488fe3d1813487192cbacca1